Please login to the form below

Not currently logged in
Email:
Password:

Agios Pharma

This page shows the latest Agios Pharma news and features for those working in and with pharma, biotech and healthcare.

Celgene, Agios get FDA OK for leukaemia drug Idhifa

Celgene, Agios get FDA OK for leukaemia drug Idhifa

Celgene and Agios Pharma have claimed FDA approval for Idhifa, a new drug that is targeted at patients with a specific genetic mutation. ... That kicked off in 2010 with a $130m upfront payment from Celgene to Agios.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Chris Bowden joins Agios Chris Bowden joins Agios

    Chris Bowden joins Agios. He is former VP, product development oncology at Genentech. ... Agios Pharma has named former Genentech VP Chris Bowden as chief medical officer.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics